The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion

Shock

Volumn 30, Issue 5, 2008, Pages 496-502

  Pan, Shiow L ^a   Tao, Kai Y ^a   Guh, Jih H ^a   Sun, Hui L ^a   Huang, Der Y ^a   Chang, Ya L ^a   Teng, Che M ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cell adhesion; Endothelial cells; Inflammation; PAR2

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE ACTIVATED RECEPTOR 2; TRANSCRIPTION FACTOR AP 2; TRYPSIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; DNA, COMPLEMENTARY; FLAVONOIDS; FLOW CYTOMETRY; HUMANS; IMIDAZOLES; INDOLES; INTEGRIN ALPHA4BETA1; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LEUKOCYTES; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTOR, PAR-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRYPSIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 55949105842     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181673233     Document Type: Article

References (41)

1. Springer TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990.
2. Battistini B, Forget MA, Laight D: Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5:167-183, 1996.
3. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothleinm R: Intercellular adhesion molecular-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456-459, 1990.
4. Isobe M, Yagita H, Okmura AK, Ihara A: Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125-1127, 1992.
5. Gimbrone MA, Nagel T Jr, Topper JN: Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 100:S61-S65, 1997.
6. Smith RE, Hogaboam CM, Strieter RM, Lukacs NW, Kunkel SL: Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion. J Leukoc Biol 62:612-619, 1997.
7. McGettrick HM, Lord JM, Wang KQ, Rainger GE, Buckley CD, Nash GB: Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium. J Leukoc Biol 79:779-788, 2006.
8. Boisvert WA: Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14:161-165, 2004.
9. Boisvert WA, Curtiss LK, Terkeltaub RA: Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21:129-137, 2000.
10. Fox EA, Kahn SR: The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94:362-365, 2005.
11. Hoffmann E, Thiefes A, Buhrow D, Dittrich-Breiholz O, Schneider H, Resch K, Kracht M: MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 280:9706-9718, 2005.
12. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847-855, 2002.
13. Dery O, Corvera CU, Steinhoff M, Bunnett NW: Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:C1429-C1452, 1998.
14. Coughlin SR: Thrombin signaling and protease-activated receptors. Nature 407:258-264, 2000.
15. O'Brien PJ, Molino M, Kahn M, Brass LF: Protease activated receptors: theme and variations. Oncongene 20:1570-1581, 2001.
16. Xu WF, Anderson H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 95:6642-6646, 1998.
17. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR: Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103:879-887, 1999.
18. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tam JC, Coughlin SR: A dual thrombin receptor system for platelet activation. Nature 394:690-694, 1998.
19. Schmidt VA, Nierman WC, Maglott DR, Cupit LD, Moskowitz KA, Wainer JA, Bahou WF: The human proteinase-activated receptor-3 (PAR-3) gene: identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. J Biol Chem 273:15061-15068, 1998.
20. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, Brass LF: Thrombin responses in human endothelial cells: contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombincleaved PAR1. J Biol Chem 275:13502-13509, 2000.
21. Lourbakos A, Potempa J, Travis J, D'Andrea MR, Andrade-Gordon P, Santulli R, Mackie EJ, Pike RN: Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 69:5121-5130, 2001.
22. Collins PW, Macey MG, Cahill MR, Newland AC: Von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells. Thromb Haemost 70:346-350, 1993.
23. Nystedt S, Ramakrishnan V, Sundelin J: The proteinase-activated receptor is induced by inflammatory mediators in human endothelial cells. J Biol Chem 271:14910-14915, 1996.
24. Vergnolle N: Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163:5064-5069, 1999.
25. Kawabata A, Kanke T, Yonezawa D, Ishiki T, Saka M, Kabeya M, Sekiguchi F, Kubo S, Kuroda R, Iwaki M, et al.: Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 309:1098-1107, 2004.
26. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756, 1973.
27. McGuire JJ, Dai J, Andrade-Gordon P, Triggle CR, Hollenberg MD: Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. J Pharmacol Exp Ther 303:985-992, 2002.
28. Pan SL, Guh JH, Peng CY, Wang SW, Chang YL, Cheng FC, Chang JH, Kuo SC, Lee FY, Teng CM: YC-1 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. J Pharmacol Exp Ther 314:35-42, 2005.
29. Pan SL, Huang YW, Guh JH, Chang YL, Peng CY, Teng CM: Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats. Biochem Pharmacol 65:1897-1905, 2003.
30. Muller WA: Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327-334, 2003.
31. Okada M, Suzuki K, Takada K, Nakashima M, Nakanishi T, Shinohara T: Detection of up-regulated genes in thrombin-stimulated human umbilical vein endothelial cells. Thromb Res 118:715-721, 2006.
32. Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel AM, Bongrand P, Kaplanski S, Farnarier C: Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecular-1 (VCAM-1; CD106). Blood 92:1259-1267, 1998.
33. Lawrence MB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859-873, 1991.
34. Lee CH, Chen HH, Hoke G, Jong JS, White L, Kang YH: Antisense gene suppression against human ICAM-1, ELAM-1, and VCAM-1 in cultured human umbilical vein endothelial cells. Shock 4:1-10, 1995.
35. Kunkel SL, Lukacs NW, Strieter RM: The role of interleukin-8 in the infectious process. Ann N Y Acad Sci 730:134-143, 1994.
36. Seo SM, McIntire LV, Smith CW: Effects of IL-8, Gro-alpha, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils. Am J Physiol Cell Physiol 281:C1568-C1578, 2001.
37. Janeway CA, Travers P Jr, Walport M, Shlomchik M: Innate immunity. Immunobiology: The Immune System in Health and Disease 5th ed. New York: Garland Publishing; 2001:35-91.
38. Page K, Hughes VS, Odoms KK, Dunsmore KE, Hershenson MB: German cockroach proteases regulate interleukin-8 expression via nuclear factor for interleukin-6 in human bronchial epithelial cells. Am J Respir Cell Mol Biol 53:225-231, 2005.
39. Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O, Koga K, Yano T, Tsutsumi O, Taketani Y: Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 20:3547-3553, 2005.
40. Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA, Steinhoff M: Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kB in human dermal microvascular endothelial cells. J Invest Dermatol 118:380-385, 2002.
41. Ma Y, Zhang B, Qian R, Lu C, Zhao F, Yin L: Tryptase activates PKB in inflammatory reaction in ECV304 cells. Biochim Biophys Acta 1763:313-321, 2006.